Rituximab for refractory granulomatous eye disease

OBJECTIVE: To determine the effectiveness of rituximab therapy for patients with granulomatous disease of the eye. METHODS: Retrospective review was undertaken of cases seen at a single institution for ocular antineutrophil cytoplasmic antibody-associated vasculitis or sarcoidosis with persistent oc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lower, Elyse E, Baughman, Robert P, Kaufman, Adam H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468281/
https://www.ncbi.nlm.nih.gov/pubmed/23055686
http://dx.doi.org/10.2147/OPTH.S35521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468281/
https://www.ncbi.nlm.nih.gov/pubmed/23055686
http://dx.doi.org/10.2147/OPTH.S35521

Ejemplares similares